-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
$17.
4 billion versus $12 billion
.
Two huge mergers and acquisitions of over US$10 billion in 2021 will change the market structure of the global CRO industry
Note: 1.
Only CXO companies listed worldwide are counted 2.
Thermo’s revenue is CXO business revenue (PPD and Patheon); 3.
ICON revenue includes PRA 2021H1 revenue; 4.
Catalent’s fiscal year is from July 2020 to 2021 June; 5.
The exchange rate is calculated according to 1 US dollar = 6.
45 RMB, 1 Swiss franc = 1.
09 US dollars
01.
Giants from mergers and acquisitions
Giants from mergers and acquisitions
The two major mergers and acquisitions of over 10 billion US dollars in the past year have directly changed the market structure of the global CRO industry
.
The first change came in February 2021, when ICON acquired PRA Health Science for $12 billion
02.
How to become the next WuXi?
How to become the next WuXi?
If you look back at the development process of the overseas CRO industry, it has gone through four stages: germination, development, maturity and integration
.
Unlike the global CRO giants that are experiencing horizontal integration and expansion, the domestic CRO industry is still in a relatively early stage of development due to its late start.
